We are live on ! Find out more
SGH

Sivik Global Healthcare Portfolio holdings

AUM $132M
1-Year Est. Return 24.1%
This Fund
S&P 500
This Quarter Est. Return
+9.49%
1 Year Est. Return
+24.1%
3 Year Est. Return
+53.78%
5 Year Est. Return
+97.1%
10 Year Est. Return
+690.63%
AUM
$512M
AUM Growth
+$238M
Cap. Flow
+$1.67M
Cap. Flow %
0.33%
Top 10 Hldgs %
60.66%
Holding
62
New
15
Increased
14
Reduced
17
Closed
13

Top Buys

Rank Stock Value
1
XBI icon
State Street SPDR S&P Biotech ETF
XBI
+$13.1M
2
LLY icon
Eli Lilly
LLY
+$8.03M
3
BMY icon
Bristol-Myers Squibb
BMY
+$5.54M
4
MRK icon
Merck
MRK
+$4.46M
5
CAH icon
Cardinal Health
CAH
+$3.8M

Top Sells

Rank Stock Value
1
TMO icon
Thermo Fisher Scientific
TMO
+$7.99M
2
ISRG icon
Intuitive Surgical
ISRG
+$7.39M
3
BDX icon
Becton Dickinson
BDX
+$7.29M
4
A icon
Agilent Technologies
A
+$6.14M
5
FMS icon
Fresenius Medical Care
FMS
+$5.35M

Sector Composition

Rank Sector Weight
1 Healthcare 54.78%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SPY icon
1
PUT
State Street SPDR S&P 500 ETF Trust
SPY
$819B
$214M 41.8%
+5,000
New +$2.09M
XBI icon
2
State Street SPDR S&P Biotech ETF
XBI
$10.1B
$13.5M 2.64%
+100,000
New +$13.1M
HUM icon
3
Humana
HUM
$43.1B
$11.1M 2.16%
25,000
+5,000
+25% +$2.18M
UNH icon
4
UnitedHealth
UNH
$369B
$11M 2.15%
27,500
+7,500
+38% +$2.99M
UHS icon
5
Universal Health Services
UHS
$10.4B
$11M 2.14%
75,000
+10,000
+15% +$1.51M
CNC icon
6
Centene
CNC
$32B
$10.2M 1.99%
140,000
+15,000
+12% +$1.03M
MOH icon
7
Molina Healthcare
MOH
$10.1B
$10.1M 1.98%
40,000
+5,000
+14% +$1.26M
THC icon
8
Tenet Healthcare
THC
$21B
$10M 1.96%
150,000
-50,000
-25% -$3.1M
MDT icon
9
Medtronic
MDT
$110B
$9.93M 1.94%
80,000
– –
ZBH icon
10
Zimmer Biomet
ZBH
$18.9B
$9.65M 1.88%
61,800
-5,150
-8% -$834K
CRL icon
11
Charles River Laboratories
CRL
$12.6B
$9.25M 1.81%
25,000
+2,500
+11% +$835K
LLY icon
12
Eli Lilly
LLY
$1.05T
$9.18M 1.79%
+40,000
New +$8.03M
JNJ icon
13
Johnson & Johnson
JNJ
$617B
$9.06M 1.77%
55,000
+20,000
+57% +$3.31M
AVTR icon
14
Avantor
AVTR
$8.92B
$8.88M 1.73%
250,000
+50,000
+25% +$1.62M
IQV icon
15
IQVIA
IQV
$38B
$8.48M 1.66%
35,000
-10,000
-22% -$2.31M
BSX icon
16
Boston Scientific
BSX
$72.1B
$8.12M 1.59%
190,000
-35,000
-16% -$1.47M
DHR icon
17
Danaher
DHR
$139B
$8.05M 1.57%
33,840
-8,460
-20% -$1.88M
MCK icon
18
McKesson
MCK
$99.4B
$7.65M 1.49%
40,000
+10,000
+33% +$1.93M
CTLT
19
DELISTED
CATALENT, INC.
CTLT
$7.57M 1.48%
70,000
-2,500
-3% -$268K
BRKR icon
20
Bruker
BRKR
$7.84B
$7.22M 1.41%
95,000
+15,000
+19% +$1.05M
BIIB icon
21
Biogen
BIIB
$30B
$6.92M 1.35%
20,000
+7,500
+60% +$2.27M
WAT icon
22
Waters Corp
WAT
$38.7B
$6.91M 1.35%
20,000
-1,500
-7% -$475K
LH icon
23
Labcorp
LH
$25.5B
$6.9M 1.35%
29,100
– –
SYK icon
24
Stryker
SYK
$129B
$6.49M 1.27%
25,000
-10,000
-29% -$2.56M
HCA icon
25
HCA Healthcare
HCA
$88.4B
$6.2M 1.21%
30,000
-10,000
-25% -$2.04M
1
2 3

Similar funds

VF
Visa Foundation San Francisco, California $132M AUM 14.62% 1-Year Est. Return
AFP
ATX Financial Planning Austin, Texas $132M AUM
GCM
Graver Capital Management Columbus, Ohio $132M AUM 16.79% 1-Year Est. Return
TCPW
Twin City Private Wealth Winston-Salem, North Carolina $132M AUM 11.31% 1-Year Est. Return
GCM
Gunpowder Capital Management Towson, Maryland $132M AUM
PF
PlanVest Financial Gaithersburg, Maryland $131M AUM
DQRIM
Dale Q Rice Investment Management Vancouver, Washington $132M AUM 45.8% 1-Year Est. Return
MFG
Macco Financial Group Green Bay, Wisconsin $132M AUM

Sivik Global Healthcare's Q2 2021 Portfolio in Review

As of Q2 2021, Sivik Global Healthcare held 62 positions worth $512M, up 87% from $274M the previous quarter. Its ten largest holdings account for 61% of the portfolio.

Sivik Global Healthcare's Q2 2021 filing shows 15 new, 14 increased, 17 reduced and 13 closed positions. Its largest new stake was State Street SPDR S&P Biotech ETF: 100,000 shares worth $13.5M. The largest sale was Thermo Fisher Scientific, an estimated $7.99M.

By sector, the portfolio is most concentrated in Healthcare at 55% of assets, down from 99% a quarter earlier.

  • Sivik Global Healthcare's largest Q2 2021 buy was State Street SPDR S&P Biotech ETF: 100,000 shares worth $13.5M.
  • Sivik Global Healthcare added most to Johnson & Johnson in Q2 2021, an estimated $3.31M increase.
  • Sivik Global Healthcare's biggest Q2 2021 reduction was Agilent Technologies, cutting an estimated $6.14M.
  • Sivik Global Healthcare fully exited Thermo Fisher Scientific in Q2 2021, selling an estimated $7.99M.
  • Sivik Global Healthcare's ten largest holdings make up 61% of its $512M portfolio in Q2 2021.
  • Sivik Global Healthcare opened 15 new positions and closed 13 in Q2 2021.
  • Sivik Global Healthcare's portfolio value rose 87% quarter-over-quarter to $512M.

Based on Sivik Global Healthcare's 13F filing for Q2 2021, filed 10 Aug 2021.